These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 36306339)
21. ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Bonnez Q; Sakai K; Vanhoorelbeke K J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834813 [TBL] [Abstract][Full Text] [Related]
22. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura. Thomas MR; de Groot R; Scully MA; Crawley JT EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702 [TBL] [Abstract][Full Text] [Related]
23. Co(III)-NTA Mediated Antigen Immobilization on a Fiber Optic-SPR Biosensor for Detection of Autoantibodies in Autoimmune Diseases: Application in Immune-Mediated Thrombotic Thrombocytopenic Purpura. Horta S; Qu JH; Dekimpe C; Bonnez Q; Vandenbulcke A; Tellier E; Kaplanski G; Delport F; Geukens N; Lammertyn J; Vanhoorelbeke K Anal Chem; 2020 Oct; 92(20):13880-13887. PubMed ID: 32929962 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan. Matsumoto M; Fujimura Y; Wada H; Kokame K; Miyakawa Y; Ueda Y; Higasa S; Moriki T; Yagi H; Miyata T; Murata M; Int J Hematol; 2017 Jul; 106(1):3-15. PubMed ID: 28550351 [TBL] [Abstract][Full Text] [Related]
25. Medical consult: aHUS, TTP? How to distinguish and what to do. Story CM; Gerber GF; Chaturvedi S Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):745-753. PubMed ID: 38066937 [TBL] [Abstract][Full Text] [Related]
26. N-glycan-mediated shielding of ADAMTS13 prevents binding of pathogenic autoantibodies in immune-mediated TTP. Ercig B; Graça NAG; Kangro K; Arfman T; Wichapong K; Hrdinová J; Kaijen P; van Alphen FPJ; van den Biggelaar M; Vanhoorelbeke K; Veyradier A; Coppo P; Reutelingsperger C; Nicolaes GAF; Männik A; Voorberg J Blood; 2021 May; 137(19):2694-2698. PubMed ID: 33544829 [TBL] [Abstract][Full Text] [Related]
27. HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR. Sakai K; Kuwana M; Tanaka H; Hosomichi K; Hasegawa A; Uyama H; Nishio K; Omae T; Hishizawa M; Matsui M; Iwato K; Okamoto A; Okuhiro K; Yamashita Y; Itoh M; Kumekawa H; Takezako N; Kawano N; Matsukawa T; Sano H; Ohshiro K; Hayashi K; Ueda Y; Mushino T; Ogawa Y; Yamada Y; Murata M; Matsumoto M Blood; 2020 Jun; 135(26):2413-2419. PubMed ID: 32253422 [TBL] [Abstract][Full Text] [Related]
28. Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A Iio R; Akiyama S; Mitsumoto K; Iwata Y; Okushima H; Shimada K; Ota N; Tomida K; Fushimi H; Shoji T; Matsumoto M; Hayashi T BMC Nephrol; 2020 Oct; 21(1):431. PubMed ID: 33046023 [TBL] [Abstract][Full Text] [Related]
29. Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura. Li D; Xiao J; Paessler M; Zheng XL Thromb Haemost; 2011 Nov; 106(5):947-58. PubMed ID: 21901237 [TBL] [Abstract][Full Text] [Related]
30. Identification of Biomarkers in Patients with Thrombotic Thrombocytopenic Purpura Presenting with Large and Small Ischemic Stroke. Lin C; Memon R; Sui J; Zheng XL Cerebrovasc Dis Extra; 2021; 11(1):29-36. PubMed ID: 33601375 [TBL] [Abstract][Full Text] [Related]